ClinicalTrials.gg
Sign In

Peri-Implantitis clinical trials

The registry lists 322 studies for Peri-Implantitis across more than 10 countries. 88 are recruiting or about to start. 287 of them are mainly about Peri-Implantitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.

Get an email when these change. Save the Peri-Implantitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
181
Recruiting
48
Status unknown
31
Not yet recruiting
29
Active, not recruiting
13
Enrolling by invitation
11

Phase

Phase 4
17
Phase 3
8
Phase 2
6
Phase 1
2
Early Phase 1
2

Where

Turkey
52
Spain
50
United States
32
Italy
29
Sweden
21
Brazil
11

Who runs them

Universitat Internacional de Catalunya (15) · Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain (13) · Universidad Complutense de Madrid (8) · University of Michigan (7) · Università Vita-Salute San Raffaele (7) · Gazi University (6) · University of Barcelona (6) · Aristotle University Of Thessaloniki (5)

What is being tested here

Drugs under test in Peri-Implantitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Azithromycin101
Chlorhexidine016
Metronidazole004
Amoxicillin003
Minocycline033
Chlorhexidine gluconate012
Hydrogen Peroxide001
Methylene Blue001
Probiotic001
Triclosan011

Coming up

0phase 3 studies under way
36studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 48 Peri-Implantitis studies recruiting now, 26 (54%) set no upper age limit and 9 (19%) stop at 75 or younger. 7 (15%) take children under 18. 0 (0%) are for women only and 1 (2%) for men only; 25 (52%) take healthy volunteers.

Recruiting studies that take each age, of 48
AgeWomenMen
107 (15%)7 (15%)
1842 (88%)43 (90%)
3046 (96%)47 (98%)
4047 (98%)48 (100%)
5047 (98%)48 (100%)
6546 (96%)47 (98%)
7541 (85%)42 (88%)
8532 (67%)32 (67%)

Across all 322 studies, recruiting or not: 23% stop at 75 or younger and 13% at 65; 10% take children; 1% are for women only and 2% for men only; 54% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Peri-Implantitis studies take

Of 126 interventional studies with no phase under Peri-Implantitis, half reached primary completion within 26 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase26 mo12–40 · 126 studies—26 mo12–46 · 119 studies
Observational17 mo8–77 · 35 studies—17 mo8–77 · 33 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 322. Browse all 322 → or search them.